Market revenue in 2023 | USD 929.5 million |
Market revenue in 2030 | USD 2,068.0 million |
Growth rate | 12.1% (CAGR from 2023 to 2030) |
Largest segment | Disposable equipment |
Fastest growing segment | Disposable Equipment |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Disposable Equipment, Capital Equipment, Reusable Equipment |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Stryker Corp, Abbott Laboratories, Smith & Nephew PLC, Johnson & Johnson, AngioDynamics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiofrequency ablation devices market will help companies and investors design strategic landscapes.
Disposable equipment was the largest segment with a revenue share of 42.79% in 2023. Horizon Databook has segmented the Asia Pacific radiofrequency ablation devices market based on disposable equipment, capital equipment, reusable equipment covering the revenue growth of each sub-segment from 2018 to 2030.
Asia Pacific is the fastest growing region in the radiofrequency ablation devices market due to increasing disposable income, improving healthcare infrastructure, and rapidly growing economic conditions in the emerging markets of China & India.
Introduction of advanced technology such as multineedle electrode with higher accuracy and cost-effectiveness as well as portability is expected to serve the market as a driver due to customizability. The significant geriatric population in Japan is at a higher risk of developing chronic diseases.
Such as cardiac disorders & cancer, which is expected to increase procedure volume. Radiofrequency ablation treatment is also used when patients become unresponsive to chemotherapy or have other medical conditions requiring an alternate treatment, which presents a lucrative growth opportunity.
Horizon Databook provides a detailed overview of continent-level data and insights on the Asia Pacific radiofrequency ablation devices market , including forecasts for subscribers. This continent databook contains high-level insights into Asia Pacific radiofrequency ablation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account